Roche (OTCMKTS:RHHBY) Sets New 1-Year High – Should You Buy?

Roche Holding AG (OTCMKTS:RHHBY) shares reached a new 52-week high during mid-day trading on Monday . The company traded as high as $44.31 and last traded at $44.24, with a volume of 7251897 shares. The stock had previously closed at $43.26.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Sanford C. Bernstein raised Roche to a “strong-buy” rating in a research note on Thursday, January 30th. UBS Group raised shares of Roche from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 13th. Finally, Morgan Stanley began coverage on shares of Roche in a research note on Wednesday, February 12th. They issued an “equal weight” rating for the company. Two investment analysts have rated the stock with a sell rating, one has given a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

Roche Stock Performance

The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97. The business’s 50-day simple moving average is $40.13 and its 200-day simple moving average is $38.54.

Hedge Funds Weigh In On Roche

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Brooklyn Investment Group purchased a new position in shares of Roche during the 3rd quarter worth approximately $40,000. IHT Wealth Management LLC purchased a new position in Roche during the third quarter valued at $236,000. Canopy Partners LLC boosted its holdings in shares of Roche by 4.6% during the 3rd quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock valued at $310,000 after buying an additional 344 shares in the last quarter. Verity Asset Management Inc. grew its position in shares of Roche by 26.8% in the 4th quarter. Verity Asset Management Inc. now owns 8,036 shares of the company’s stock worth $280,000 after buying an additional 1,697 shares during the period. Finally, HighPoint Advisor Group LLC increased its stake in shares of Roche by 2.8% in the 4th quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company’s stock worth $387,000 after acquiring an additional 304 shares in the last quarter.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.